Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis

BACKGROUND: The prognosis of patients with combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma (CHC) is usually poor, and effective adjuvant therapy is missing making it important to investigate whether these patients may benefit from adjuvant transarterial chemoembolization (TACE)...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:BMC Cancer
المؤلفون الرئيسيون: Liu, Wei-Ren, Tian, Meng-Xin, Tao, Chen-Yang, Tang, Zheng, Zhou, Yu-Fu, Song, Shu-Shu, Jiang, Xi-Fei, Wang, Han, Zhou, Pei-Yun, Qu, Wei-Feng, Fang, Yuan, Ding, Zhen-Bin, Zhou, Jian, Fan, Jia, Shi, Ying-Hong
التنسيق: Artigo
اللغة:Inglês
منشور في: BioMed Central 2020
الموضوعات:
Research Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7350756/
https://ncbi.nlm.nih.gov/pubmed/32650743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07138-z
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة